Serum Biomarkers in Children with Acute Severe Bronchial Asthma
International Journal of Current Pharmaceutical Review and Research · 05.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 05.03.2026. Verfasst von Shaik Ameer Malik und 2 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The National Institutes of Health (NIH) describes asthma as a "Chronic-inflammatory" disease that affects the airways. Over the past few years, there has been an increase in the prevalence of asthma not just in our nation but also globally. Asthma affects the lungs, as we all know, but in cases of acute severe asthma, a hypoxic state can also impact other important organs. In a 2018 study, cardiac biomarkers in acute severe asthma were assessed by a tertiary care hospital of Northern India. Studies on adults with acute severe asthma have demonstrated the involvement of other essential organs as well, although there is insufficient evidence for the paediatric age range. Therefore, the purpose of this study is to assess the dysfunction of the heart, liver, and kidneys in patients with acute severe bronchial asthma based on the baseline biomarker levels at admission and determine whether or not this dysfunction persisted even after the patient's stabilization.
Methods
An observational, prospective study conducted over 18 months. The children of age group 3-12 years who presented with acute severe bronchial asthma (pulmonary score > 6) were enrolled into the study after taking informed consent from the parents/guardian and carefully ruling out exclusion criteria. The objective of the study was to evaluate the involvement of vital organs in acute severe asthma in children through estimation of serum levels of cardiac biomarkers [Troponin I, CPK-MB], liver biomarkers [ALT and AST] and kidney biomarkers [Blood urea nitrogen and serum Creatinine]. Blood sample was taken within 12 hours of admission, serve as baseline investigation. Another sampling was done at 48 hours of admission, and these investigations compared with the baseline investigations Result: A total of 65 patients with asthma severity score more than 6 were included in the study. Majority (43.1%) of the children were of the age group of 8-10. The mean age was 10.3 years. Majority (55.38%) of the children were male. 83.07% of the cases had oxygen saturation below 90%, 10.7% had oxygen saturation between 91-95% and 6.1% had oxygen saturation above 95%. There was no statistically significant difference found between the values at the time of admission and 48 hours later in the level of cardiac, liver and kidney biomarkers.
Conclusion
This study concludes that in acute severe asthmatics children between 3-12 years of age, there was no association found in the serum biomarkers level of vital organs like Heart, Liver and Kidney at the time of admission and after 48 hours.
Zitieren
APA
Malik, S. A., Kumar, A., & Uppal, V. (2026). Serum Biomarkers in Children with Acute Severe Bronchial Asthma. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.17
Vancouver
Malik SA, Kumar A, Uppal V. Serum Biomarkers in Children with Acute Severe Bronchial Asthma. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.17
BibTeX
@article{Malik2026,
author = {Malik, Shaik Ameer and Kumar, Ajay and Uppal, Vibha},
title = {Serum Biomarkers in Children with Acute Severe Bronchial Asthma},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.17}
}
EUVIMED